What Is PEG-MGF?
PEG-MGF is a polyethylene glycol-modified form of Mechano Growth Factor (MGF). MGF is an alternatively spliced form of insulin-like growth factor 1 (IGF-1), identified as IGF-1Ec in humans.
MGF contains a distinct C-terminal E-domain generated through alternative splicing of the IGF-1 gene. Published studies have examined MGF and its E-domain peptide as distinct molecular forms.
Research Overview Table
Chemical and Molecular Characteristics
Certificates:
Mechanism of Action Under Investigation
A specific molecular target for PEG-MGF has not been established in published experimental studies. Mechanistic findings available for the underlying MGF E-domain peptide are inconsistent. One study reported that MGF-E activity involved a receptor other than IGF-1R, while another found that E-peptide effects required functional IGF-1R signaling.
Synthetic MGF has also been reported to increase phosphorylation of ERK1/2 and ERK5 without detectable IGF-1R phosphorylation. In human intestinal smooth muscle cells, MGF produced ERK5 nuclear translocation, whereas IGF-1 activated IGF-1R and downstream Akt signaling. These findings indicate that MGF-related signaling may differ from canonical IGF-1 signaling.
The mechanism therefore remains unresolved. In particular, published studies have not established how PEG modification changes MGF receptor interaction, intracellular signaling, or downstream biochemical activity. Findings from MGF or MGF-E peptides cannot be assumed to represent the mechanism of PEG-MGF.
Scientific Research Context
PEG-MGF appears in the literature mainly in relation to its parent peptide, Mechano Growth Factor (MGF), and the MGF E-domain peptide. Published studies have examined these non-PEGylated forms in cultured human and animal cells, muscle related systems and preclinical animal models. Direct evidence for the PEGylated compound remains limited, with no distinct body of published cell or animal studies established for PEG-MGF itself.
PEG-MGF Biology and Biological Pathways
Primary Biological Function
Published studies do not define a biological function for PEG-MGF itself. The closest primary literature concerns MGF/IGF-1Ec and its E-domain peptide, which has been studied in relation to skeletal-muscle cell proliferation, differentiation, migration and fusion. These findings describe MGF-related biology and should not be assigned directly to PEG-MGF.
Relevant Metabolic or Signalling Pathways
Researchers have examined ERK1/2, ERK5, and PI3K-Akt pathways in MGF E-peptide studies because these pathways are linked to cellular responses measured in the published experiments. MGF E-peptide activated ERK1/2 in several studies, while PI3K-Akt involvement was reported under specific experimental conditions. ERK5 activation has also been reported with synthetic MGF.
Tissue-Specific Biology
Published studies have examined MGF/IGF-1Ec in skeletal muscle, heart, brain, bone and tendon. MGF expression has been reported in muscle, bone, and tendon after mechanical stress, and in heart and brain following ischemic injury. Comparable tissue specific findings have not been established for PEG-MGF itself.
Experimental Biomarkers
Published MGF studies have measured MGF/IGF-1Ec expression, MyoD, ERK1/2 phosphorylation, ERK5 phosphorylation, and Akt phosphorylation. Studies have also measured proliferation, differentiation, migration, and fusion as biological endpoints. These markers and endpoints have been investigated for MGF or MGF E-peptide, not specifically for PEG-MGF.
Laboratory Investigation Methods
Published MGF research has used muscle biopsy analysis, cell culture, gene-expression analysis, immunoblotting, immunostaining, phosphorylation assays, and cell-based proliferation and migration measurements. Mass spectrometry has also been used to characterize full-length MGF. These methods have been applied to MGF and MGF-derived peptides rather than establishing equivalent biological properties for PEG-MGF.
Experimental Models Used in Published Research
No primary peer-reviewed study was identified that experimentally tested PEG-MGF itself in a cell, animal or human model. The published experimental literature located for this compound concerns unmodified MGF or MGF E-domain peptide, so those models should not be presented as PEG-MGF-specific models.
C2C12 Myoblasts
C2C12 mouse myoblasts are an established cell-line model. The main limitation is that an immortalized mouse cell line does not fully represent primary human muscle cells or intact human tissue.
Human Muscle Progenitor Cells
Primary human muscle progenitor cells are a relevant human cell model used in MGF E-peptide research. Their main limitation is that cultured cells lack the native tissue environment of skeletal muscle. Donor age and differences between cell cultures can also affect experimental responses.
Porcine Satellite Cells
Porcine satellite cells are primary skeletal muscle progenitor cells isolated from pig muscle. Their use as an in-vitro model is limited by species specific biology and by changes in cell characteristics during culture and repeated passage, which can alter proliferation and differentiation properties.
Mouse Models
Mouse models include wild-type and SCID mice in the published MGF-E literature. Their main limitations are species-specific differences and the inability of an animal model to reproduce all aspects of human biology.
Rabbit Models
Researchers have used rabbit models in MGF-E research. Their main limitation is the anatomical and physiological differences between rabbits and humans, which limit direct translation of findings.
Sheep Models
Sheep provide a large-animal model. Their main limitation is differences between sheep and human physiology, which limit direct extrapolation to human biology.
PEG-MGF Published Research
The published studies discussed below concern MGF or MGF-derived peptides, not PEG-MGF.
IGF-1 Splice-Variant Biology
Studies have examined IGF-1Ec/MGF expression, alternative IGF-1 splicing, and production of the associated E-domain peptide in human skeletal muscle. Research has also examined the presence and regulation of the Ec/Eb peptide in human and rodent tissues.
Skeletal Muscle Cell Biology
MGF E-domain studies have examined human muscle progenitor cells and C2C12 myoblasts, including cellular proliferation, differentiation, fusion, and migration. Other experiments have compared cellular responses to MGF E-peptide with those produced by mature IGF-1.
Cardiac Biology
Research has examined MGF E-domain biology in relation to cardiac function, protein–protein interactions and regulation of cardiac contractile proteins. Investigations have included interactions involving 14-3-3γ, myosin-binding protein C, and phospholamban, as well as changes associated with Ser18 phosphorylation of the E-domain. These findings relate to MGF E-domain peptides, not PEG-MGF.
Bone Biology
Researchers have studied the MGF E-peptide for osteoblast proliferation, differentiation and mineralization. Reported effects on these processes have differed between experimental studies. The evidence concerns MGF E-peptide, not PEG-MGF.
Limitations of Current Research
Evidence Is Predominantly Preclinical
The available experimental literature concerns MGF and MGF-derived E-peptides, rather than PEG-MGF itself. Studies include cultured human and animal cells and animal experiments. Direct experimental evidence for the PEGylated compound is therefore not established in the peer-reviewed literature.
Human Clinical Evidence
No controlled human clinical studies of PEG-MGF were identified. Human evidence in the related MGF literature includes studies using human-derived cells and muscle biopsy samples. But these are not clinical administration studies and do not provide clinical evidence for PEG-MGF.
Species Differences
The MGF literature includes human cells as well as rodent and other animal systems. Differences between species can affect peptide biology, tissue responses, and IGF-1-related signaling. Findings from animal studies therefore cannot be assumed to represent human responses, particularly for a PEGylated form that has not been directly studied.
Study Design Limitations
MGF studies differ substantially in peptide sequence, experimental system, exposure conditions and study design. For example, findings regarding E-peptide signaling have differed between studies, including differing observations concerning dependence on IGF-1 receptor signaling. These differences make direct comparison across experiments difficult.
Independent Replication
No independent replication of PEG-MGF specific findings has been established in the peer-reviewed literature. No primary experimental study of PEG-MGF itself was identified, so there are no independently reproduced PEG-MGF findings to compare across research groups.
Long-Term Evidence
The peer-reviewed literature does not provide long term data for PEG-MGF. No primary study has established prolonged exposure, long-term biological effects or long-term safety of the PEGylated compound. The available MGF research does not establish these outcomes for PEG-MGF.
Analytical Documentation
HPLC can assess peptide purity and related substances. LC-MS can support molecular-mass and identity assessment. NMR can provide additional structural information when appropriate for the sample.
A Certificate of Analysis (COA) records analytical results for a specific batch or lot. Such documentation helps establish the identity and quality of material used in laboratory research and supports reproducibility.
Analytical documentation verifies product identity and quality, not biological performance.
Storage and Laboratory Handling
PEG-MGF should remain at 2–8°C, according to the product specification shown in the Certificate of Analysis. Laboratory personnel should handle the material using appropriate laboratory practices, and qualified personnel should oversee its storage and handling.
Clean handling procedures should help prevent contamination during laboratory use. The material should remain protected from unnecessary exposure to conditions that could affect its quality or identity. Handling areas and equipment should be suitable for peptide research.
Why Researchers Choose Direct SARMs?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.